Volume 199, Issue 3 , Pages 224-231, September 2008
Maternal morbidity following a trial of labor after cesarean section vs elective repeat cesarean delivery: a systematic review with metaanalysis
Article Outline
This study reviewed maternal morbidity following trial of labor (TOL) after cesarean section, compared with elective repeat cesarean delivery (ERCS). Articles were pooled to compare women planning vaginal birth after cesarean (VBAC) with those undergoing ERCS with regard to maternal morbidity (MM), uterine rupture/dehiscence (UR/D), blood transfusion (BT), and hysterectomy. The former group was subdivided into successful VBAC (S-VBAC) and failed TOL (F-TOL). VBAC was successful in 17,905 of 24,349 patients (73%). MM, BT, and hysterectomy were similar in women planning VBAC or ERCS, whereas UR/D was different (1.3%; 0,4%). MM, UR/D, BT and hysterectomy were more common after F-TOL (17%, 4.4%, 3%; 0.5%) than after S-VBAC (3.1%, 0.2%, 1.1%; 0.1%) or ERCS (4.3%, 0.4%, 1%; 0.3%). Outcomes were more favorable in S-VBAC than ERCS. These findings show that a higher risk of UR/D in women planning VBAC than ERCS is counterbalanced by reduction of MM, UR/D. and hysterectomy when VBAC is successful.
Key words: elective repeat cesarean delivery, trial of labor, uterine dehiscence, uterine rupture, vaginal birth after cesarean section
Before the 1970s, deliveries by cesarean section were considered as indication for cesarean section in the subsequent pregnancies, reflecting a concern that uterine scar tissue might rupture during labor.1 In the 1980s, the dictum “once a cesarean, always a cesarean,” espoused by Craigin in 1916,2 was revised in many countries, and a trial of labor in women with history of cesarean section was proposed as an attempt to reduce cesarean section rates.3, 4, 5 However, an apparent increase in the incidence of uterine rupture and concern about maternal and fetal safety have challenged the choice of vaginal delivery in women having a scarred uterus. As a consequence, clinicians are increasingly being faced in deciding the mode of delivery in pregnant women whose first delivery was by cesarean section.
A metaanalysis of articles published in the period 1982-1989 failed to identify advantages for elective repeat cesarean delivery, compared with trial of labor, with regard to uterine rupture and perinatal death.3 In contrast, a metaanalysis of subsequent investigations published from 1989 to 1999 reported a higher rate of uterine rupture and perinatal death following a trial of labor than following elective cesarean section.5 The aim of this study was to review publications available in literature from the period of 2000 through 2007, which compared maternal morbidity after a trial of labor vs elective repeat cesarean delivery and assessed risk factors for failure of vaginal birth after cesarean delivery.
Materials and methods
A search in PubMed was performed in the period 2000-2007 to find relevant articles that compared maternal morbidity in women who had a trial of labor (TOL) vs women undergoing elective repeat cesarean section (ERCS) without labor and/or analyzed risk factors for unsuccessful TOL. Key words were vaginal birth after cesarean section (VBAC), uterine rupture, uterine dehiscence, previous cesarean, caesarean section, risk factors, trial of labor, and uterine scar. Articles were included in review and metaanalysis if they met the following inclusion criteria: rate of TOL and ERCS clearly reported in tables or text, failed TOL (F-TOL) defined as the rate of patients who planned VBAC but subsequently delivered by emergency cesarean section and study population represented by singleton pregnancies with delivery after 20 weeks of gestation, or a newborn infant weighting 500 g or more.
Exclusion criteria were omitting of at least 1 inclusion criterion; induction of labor for termination of pregnancy or intrauterine fetal death; studies performed in selected population, such as multiparous women, postterm pregnancies, and multiple pregnancies; studies conducted in developing countries because of differences in medical practice; and number of subjects in the TOL and ERCS groups reported in graphs or percentage. Letters, comments, reviews, personal communications, and non–English-language publications were also excluded.
The study population was divided into 2 groups: patients who planned VBAC and patients who planned ERCS. The first group was further subdivided into women who successfully delivered vaginally and women who failed a trial of labor and underwent emergency cesarean section (F-TOL). The following comparisons were performed with regard to any type of maternal morbidity, uterine rupture/dehiscence, and medical interventions (blood transfusion and hysterectomy) associated with F-TOL: planned VBAC vs ERCS; F-TOL vs successful VBAC; F-TOL vs ERCS; and successful VBAC vs ERCS.
Uterine rupture/dehiscence included both rupture (disruption of the myometrium and visceral peritoneum) and dehiscence (disruption of the uterine muscles with intact serosa). Data about uterine rupture were collected if the injury was diagnosed with intraoperative finding of fetal parts within the abdominal cavity or with clinical symptoms such as abnormal fetal heart rate tracing, abdominal pain, loss of engagement of the presenting fetal parts, and intraperitoneal or vaginal hemorrhage requiring emergency laparotomy. Data about uterine dehiscence were abstracted if the injury was diagnosed by the detection of a “window” in the lower uterine segment with either membranes bulging or fetal parts visualized through it.
In a second step, risk factors for failure of VBAC were reviewed.
Metaanalysis was performed following the guidelines proposed by the Metaanalysis of Observational Studies in Epidemiology Group.6 Interstudies heterogeneity, defined according to Higgins et al7 as the percentage of total variation across studies because of heterogeneity rather than chance (I2), was tested with χ2 test for heterogeneity at a significant level of P = .10 and a random-effect model was generated whenever the I2 statistics were greater than 25%. Categorical variables were examined with calculation of pooled odds ratios (ORs) with 95% confidence interval (CI). Intergroup comparison was considered statistically significant at an alpha level of 2-tailed P < .05 if CIs did not encompass 1.0. Metaanalysis was performed with RevMan (Revision Manager, version 4.2 for Windows, The Nordic Cochrane Centre, The Cochrane Collaboration, Copenaghen, Denmark, 2003).
Results
Articles were subgrouped in studies that assessed maternal morbidity rates in women undergoing a TOL vs women opting for ERCS and studies that investigated the risk factors for failure of a TOL.
Maternal morbidity analysis
Maternal morbidity was compared between planned VBAC and planned ERCS in 7 studies.2, 8, 9, 10, 11, 12, 13 They were pooled for metaanalysis and provided 24,349 (57%) women who planned VBAC and 18,621 (43%) who planned ERCS. Women who attempted VBAC were further subdivided in a successful VBAC group and a F-TOL group for a total of 17,905 (73%) and 6444 (27%) women, respectively. Therefore, the overall successful rate of vaginal delivery in patients who attempted a trial of labor after previous cesarean section was 73% (range 68%9 to 77%13). The Table shows the characteristics of each study. The incidence of maternal morbidity, uterine rupture/dehiscence, blood transfusion, and hysterectomy in each study group is represented in Figure 1.
TABLE. Characteristics of each study
| Author | Characteristic of the study | Sample size (% of S-VABC in women planning VBAC) | Maternal morbidity, n (%) | Type of maternal morbidity and medical intervention | Uterine lesions, n (%) |
|---|---|---|---|---|---|
Bais et al | Prospective, nonrandomized | 142 42 68 | 11 14 11 | Blood transfusion, postpartum fever, hysterectomy, uterine lesions | 0 1 0 |
Blanchette et al | Prospective, nonrandomized | 577 177 727 | 17 21 33 | Amnionitis, endometritis, abdominal wound infection, blood transfusion, retained products of conception, operative injury, postpartum hemorrhage, uterine lesions | 0 12 0 |
Hibbard et al | Retrospective | 908 416 431 | 143 165 64 | Hysterectomy, blood transfusion, chorioamnionitis, endometritis, uterine lesions | 4 10 2 |
Kwee et al | Prospective, nonrandomized | 2487 787 1295 | 2 46 1 | Hysterectomy, injury of the ureter, uterine lesions | 2 46 1 |
Landon | Prospective, nonrandomized, multicenter | 13139 4759 15801 | 208 814 635 | Hysterectomy, thromboembolic disease, blood transfusion, endometritis, broad ligament hematoma, cystotomy, bowel injury, ureteral injury, uterine lesions, maternal death | 33 210 76 |
Spaans et al | Retrospective | 105 42 67 | 0 0 1 | Uterine lesions | 0 0 1 |
Tan et al | Retrospective | 547 221 232 | 47 19 | Hysterectomy, blood transfusion, operative injuries, uterine lesions | 2 0 |

FIGURE 1.
Outcomes of interest in the 4 study groups
Rossi. Maternal morbidity following a trial of labor after cesarean section vs elective repeat cesarean delivery. Am J Obstet Gynecol 2008.
Planning VBAC vs ERCS
Three studies were concordant in finding a higher maternal morbidity rate when VBAC was planned in contrast to ERCS,9, 10, 11 whereas 4 studies did not report a significant difference between the 2 modes of delivery.2, 8, 12, 13 Metaanalysis showed that maternal morbidity did not differ between women planning VBAC and patients undergoing ERCS (planned VBAC: 1642 of 24,349, 6.7%; ERCS: 757 of 18,621, 4%; Z = 1.55; P =. 12). Uterine rupture/dehiscence was reported in each investigation and incidence ranged from 0%2 to 6.7%8 in the planned VBAC group and from 0%8, 12, 13 to 1.5% 2 in ERCS group.
Three studies observed a higher incidence of uterine rupture/dehiscence in women planning VBAC, compared with women choosing ERCS.8, 10, 11 Metaanalysis showed a significant difference in uterine rupture/dehiscence between the 2 groups (planning VBAC: 320 of 24,349; 1.3%; ERCS: 80 of 18,621; 0.4%; Z = 2.55; P =. 01; OR 3.13; 95% CI 1.30 to 7.50) (Figure 2).

FIGURE 2.
Uterine rupture/dehiscence in women planning VBAC vs those opting for an ERCS
Rossi. Maternal morbidity following a trial of labor after cesarean section vs elective repeat cesarean delivery. Am J Obstet Gynecol 2008.
Blood transfusion was reported in 5 studies.8, 9, 11, 12, 13 Overall, it was required in 362 of 20,928 (1.7%) cases of planned VBAC and 187 of 17,259 (1.2%) cases of ERCS without differences between the 2 groups (Z = 0.18; P =. 86).
Hysterectomy was reported in 5 studies,9, 10, 11, 12, 13 of which in only 1 the procedure was not necessary in any group,13 and in the other 4 articles, no differences were noted between women planning VBAC and women undergoing ERCS. Considered as a whole, hysterectomy was performed in 52 of 23,448 (0.2%) cases of planned VBAC and 49 of 17,827 (0.3%) cases of ERCS without a significant difference (Z = 1.00; P =. 32).
Successful VBAC vs F-TOL
Six studies compared maternal morbidity and uterine rupture/dehiscence in women with successful VBAC vs those for whom a TOL failed.2, 8, 9, 10, 11, 13 All the studies were concordant in finding a lower morbidity rate in women destined to deliver vaginally, compared with women with F-TOL. Metaanalysis confirmed that maternal complications occurred less frequently in the successful VBAC (533 of 17358; 3.1%) than the F-TOL group (1062 of 6223; 17%; Z = 6.66; P < .0001; OR 0.15; 95% CI, 0.09 to 0.26) (Figure 3, A). When VBAC was successful, uterine rupture/dehiscence occurred in 02, 8, 13 to 0.4%,9 whereas in women experiencing F-TOL, uterine rupture/dehiscence ranged from 0%2 to 6.7%.8 All but 1 study 13 found a decreased risk of uterine rupture/dehiscence in women with successful VBAC, compared with women with F-TOL. Metaanalysis reported that women with successful VBAC were affected with uterine rupture/dehiscence less frequently than woman in the F-TOL group (successful VBAC: 39 of 17,358; 0.2% vs F-TOL: 279 of 6223; 4.4%; Z = 6.30; P < .0001; OR 0.05; 95% CI 0.02 to 0.13) (Figure 3, B).

FIGURE 3.
Comparison of outcomes in women destined to successful VBAC vs those with failure of TOL
Rossi. Maternal morbidity following a trial of labor after cesarean section vs elective repeat cesarean delivery. Am J Obstet Gynecol 2008.
Four studies8, 9, 11, 13 assessed blood transfusion in successful VBAC and F-TOL. The pooled analysis showed that women with successful VBAC (162 of 14,766; 1.1%) required blood transfusion less frequently than women with F-TOL (164 of 5394; 3%; Z = 9.35; P < .0001; OR 0.35; 95% CI, 0.28 to 0.44) (Figure 3, C).
In 3 studies hysterectomy was stratified for successful VBAC and F-TOL groups, and results were controversial: in 1 article13 the surgical procedure was not performed in any groups, in another article9 hysterectomy was equally necessary in both the 2 groups, and in a third article,11 women with successful VBAC were less likely to undergo hysterectomy than women with F-TOL. The metaanalysis of these 3 articles proved that successful VBAC (21 of 14,189; 0.1%) was less likely associated with hysterectomy than F-TOL (26 of 5217; 0.5%; Z = 4.09; P < .0001; OR 0.30; 95% CI, 0.17 to 0.53) (Figure 3, D).
F-TOL vs ERCS
Comparison of maternal morbidity and uterine rupture/dehiscence between F-TOL and ERCS was performed in 6 articles.2, 8, 9, 10, 11, 13 All but 1 study2 were concordant in detecting a higher rate of maternal morbidity when TOL failed than when ERCS was performed. Considered as a whole, maternal complications occurred less frequently in the ERCS (738 of 18,389; 4.3%) group than the F-TOL group (1062 of 6223; 17%; Z = 6.64; P < .0001; OR 0.25; 95% CI, 0.16 to 0.37) (Figure 4, A). When the incidence of uterine rupture/dehiscence was stratified in the F-TOL and ERCS groups, 2 investigations2, 13 reported a similar rate in the 2 groups, whereas the other 4 articles8, 9, 10, 11 observed a lower rate of uterine rupture/dehiscence in favor of ERCS. Metaanalysis showed that uterine rupture/dehiscence was higher in the F-TOL group than ERCS (279 of 6223; 4.4% vs 80 of 18,389; 0.4%, respectively; Z = 4.28; P < .0001; OR 11.34; 95% CI, 3.73 to 34.50) (Figure 4, B).

FIGURE 4.
Comparison of outcomes in women with F-TOL vs those opting for an ERCS
Rossi. Maternal morbidity following a trial of labor after cesarean section vs elective repeat cesarean delivery. Am J Obstet Gynecol 2008.
Similarly, in 4 studies8, 9, 10, 11 the incidence of blood transfusion was higher in F-TOL than ERCS (164 of 5393; 3% vs 170 of 17027; 1%; Z = 10.04; P < .0001; OR 3.05; 95% CI, 2.45 to 3.80) (Figure 4, C). No differences were detected in hysterectomy between F-TOL and ERCS in either single investigations9, 11, 13 or metaanalysis (F-TOL: 26 of 5217, 0.5% vs ERCS: 47 of 16,300; 0.3%; Z = 1.09; P = .27).
Successful VBAC vs ERCS
Maternal morbidity, distinguished between the 2 groups in 6 publications,2, 8, 9, 10, 11, 13 was slightly lower following successful VBAC (533 of 17358; 3.1%) than ERCS (738 of 18389; 4%), although the statistical difference was minimal (Z = 2.11; P = .04; OR 0.74; 95% CI, 0.56 to 0.98) (Figure 5, A).

FIGURE 5.
Comparison of outcomes in women with successful VBAC vs those opting for an ERCS
Rossi. Maternal morbidity following a trial of labor after cesarean section vs elective repeat cesarean delivery. Am J Obstet Gynecol 2008.
Similarly, uterine rupture/dehiscence occurred less frequently in women with successful VBAC (39 of 17358; 0.2%) than women undergoing ERCS (80 of 18389; 0.4%, Z = 3.14; P = .002; OR 0.54; 95% CI, 0.37 to 0.79) (Figure 5, B).
The pooled analysis of four studies8, 9, 11, 13 also showed that 162 of 14,766 (1.1%) women with successful VBAC required blood transfusion as well as women with ERCS (170 of 17,027; 1%; Z = 0.72; P = .47). In three studies9, 11, 13 hysterectomy was stratified for the successful VBAC and ERCS groups, of which in 2 studies9, 13 there was not a statistical difference, and 1 publication reported results in favor of successful VBAC women. The metaanalysis of these 3 articles proved that successful VBAC (21 of 14,189; 0.1%) was less likely related to hysterectomy than ERCS (47 of 16,300; 0.3%; Z = 2.52; P = .01) (Figure 5, C).
Risk factor analysis
Twelve articles assessed risk factors for failure of a TOL but could not be pooled in a metaanalysis because the study groups were not comparable. In these studies, factors that have been associated with F-TOL included the following: short interpregnancy interval,14 birthweight,15 no history of previous vaginal delivery,16, 17, 18, 19, 20, 21 maternal diabetes,16 obesity,22, 23 excessive weight gain,23 patients with multiple prior cesarean deliveries,24 cephalopelvic disproportion,21 alcohol and cigarette use, and lesser degrees of cervical dilatation at admission.20, 25
The risk of uterine rupture/dehiscence after induction of labor in women with previous cesarean section and attempting VBAC in the next pregnancy could be assessed with metaanalysis. Nine publications were reviewed. Induction of labor was achieved with prostaglandins and/or oxytocin in 6 studies,8, 10, 11, 26, 27, 28 only prostaglandins in 2 investigations,29, 30 and only oxytocin in another publication.19 Seven studies8, 10, 11, 19, 26, 29, 30 were concordant in determining a higher incidence of uterine lesion following induced labor, compared with spontaneous onset of labor, whereas in 2 studies,27, 28 no statistical difference was detected between the 2 groups. The metaanalysis calculated that the overall risk of uterine rupture was significantly higher following labor induction, compared with spontaneous labor (induced labor: 208 of 15,018, 1.3%; spontaneous labor: 184 of 34,236, 0.5%; Z = 6.95; P < .0001; OR 2.83; 95% CI, 2.11 to 3.80) (Figure 6).

FIGURE 6.
Risk of uterine rupture in induced vs spontaneous labor
Rossi. Maternal morbidity following a trial of labor after cesarean section vs elective repeat cesarean delivery. Am J Obstet Gynecol 2008.
Comment
This review shows that TOL after previous cesarean section is associated with a successful rate of 73%, and the incidence of maternal morbidity is similar in women experiencing a TOL and women choosing ERCS. Uterine injury occurs in 1.3% and 0.4% of women undergoing TOL and ERCS, respectively, and the risk of uterine lesions is 3-fold greater in patients planning VBAC, compared with those undergoing ERCS. Additional interventions, in particular blood transfusion and hysterectomy, are performed with the same frequency in the 2 groups. Our findings are similar to the results presented in metaanalysis by Mozurkewich and Hutton,5 although the incidence of uterine lesions was lower than the incidence reported in our analysis. A possible explanation may be that in the previous review, only symptomatic ruptures were analyzed, whereas in our paper dehiscence was also considered for analysis.
We did further comparison between failed vs successful VBAC as well as vs ERCS. In this analysis we determined that women who experienced failure of VBAC present an increased risk of maternal adverse outcomes, compared with both latter groups. In particular, when a TOL fails, maternal morbidity is 17%, which is much higher than 3.1% assessed in women destined to successful vaginal delivery. Uterine lesions are also observed more often following a failed TOL (4.4%), in contrast to a successful VBAC (0.2%), and this finding might explain why blood transfusion and hysterectomy are more often required in the former than the latter group. These findings suggest that, when TOL fails, adverse outcomes are more likely to occur than when VBAC is successful.
The differences that we observed between women in which VBAC ended successfully and those who underwent ERCS are in contrast to our expectation but are probably not clinically meaningful and may depend on the small number of studies, of which 111 contributed with a very high weight in the metaanalysis.
Because the increased maternal morbidity in women attempting a TOL is primarily detected when TOL fails, the identification of factors associated with failed TOL is mandatory in selecting patients who may be considered as VBAC candidates. Therefore, many studies focussed on risk or predictive factors of unsuccessful VBAC. History of a previous spontaneous vaginal delivery before the initial cesarean delivery has been revealed as a good predictor for successful TOL. Kayani and Alfirevic27 observed that of 107 women with previous cesarean section but no history of vaginal delivery, induction of labor was successful in a subsequent pregnancy in 41% of cases, compared with 83% of women who had experienced a previous vaginal delivery. Similar findings were validated by Landon et al,25 who described that women with previous vaginal delivery achieve a higher rate of VBAC success (87%) than women without a history of previous vaginal birth (61%). Blanchette et al8 achieved a VBAC success rate of approximately 90% among women with previous vaginal delivery.
Other demographic and clinical characteristics clearly associated with successful VBAC are maternal age under 40 years, cervical dilatation greater than 4 cm at admission, birthweight less than 4000 g,25 whereas history of dystocia, multiple prior cesarean deliveries, alcohol and cigarette use,20 cephalopelvic disproportion,21 and obesity31 are associated with failure of TOL and increased maternal morbidity. However, in a study conducted to identify clinical factors that could predict failure of a TOL, Srinivas et al21 showed that in a logistic regression model, which included gestational age at delivery, maternal age, maternal race, labor type, history of vaginal delivery, cephalopelvic disproportion, and prior cesarean indication, VBAC failure could not be reliably predicted.
Induction of labor has been advocated as a risk factor for uterine lesions, although studies on this topic have led to controversial results. Kayani and Alfirevic27 observed 4.7% of uterine lesions without a significant difference between induction and spontaneous labor. Induction with prostaglandins was associated with a higher rate of failure (43%) than induction with artificial rupture and oxytocin (25%; OR 6.8; 95% CI, 3.4 to 13.9). Similarly, Delaney et al28 observed that, although a higher maternal morbidity rate was more frequent in women undergoing induced (23%) than spontaneous labor (19%; OR 1.4; 95% CI, 1.2 to 1.7), the risk of uterine rupture did not differ between groups with respective rates of 1.1% with prostaglandins induction, 0.7% with oxcytocin induction, and 0.3% with spontaneous labor. Moreover, procedures in terms of blood transfusion and hysterectomy were equally performed in patients with induced (0.9%) and spontaneous (0.5%) labor.28 Chilaka et al32 obtained concordant results: no cases of uterine rupture were detected in women with successful versus failed induction after previous cesarean surgery, suggesting that induction of labor can be performed safely in women who are VBAC candidates.
Unlike the aforementioned studies, Lin and Raynor26 reported that induction of labor carries an increased risk of uterine injury but did not differ with regard to the induction agent. Lydon-Rochelle et al29 confirmed that the risk of uterine rupture is higher among patients whose labor is induced, particularly when prostaglandins are used. Another study demonstrated that women exposed to oxytocin were more likely to be affected with uterine lesion than women who were not exposed and found a relationship between doses of oxytocin and risk of uterine injury.19 When these studies were pooled, we observed that uterine lesions might be approximately 3 times as common among women undergoing induction of labor than among women delivering after spontaneous labor. Noteworthy, in a study with a very large sample size, the authors were unable to identify reliable predictors of uterine rupture.17
Caution should be exercised in interpreting our results. By reviewing current literature, there is evidence of a substantial heterogeneity across studies concerning the selection of the study sample, definition, and management of uterine lesions and assessment of maternal complications. Moreover, women with a prior cesarean section who attempt VBAC present characteristics different from those opting for an ERCS in terms of age, body mass index, and weight gain and tend to have fewer medical problems.17 Such variables can represent confounding factors that can be controlled only performing randomized, controlled studies. Therefore, the absence of randomized, controlled studies in current literature does not allow driving definitive conclusion about VBAC safety. Literature also lacks of studies investigating the long-term complications, such as incontinent of urine and feces and pelvic organ prolapse, in women with previously scarred uterus and vaginal delivery in their next pregnancy. The absence of neonatal outcome data also precludes any further safety conclusion. However, the metaanalysis has the advantage to get a large sample size, which is necessary when variables under examinations are infrequent, as the case of uterine rupture.
In conclusion, our findings suggest that an increased risk of uterine disruption may result from a plan of trial of labor with respect to elective repeat cesarean delivery. However, this increase may be counterbalanced by reduction of maternal morbidity, uterine lesions, and hysterectomy when a trial of labor is successful. Thus, because in women attempting VBAC the higher morbidity rates are encountered in those who failed to achieve vaginal birth, many studies have concentrated on identification of risk factors for failure of a trial of labor to minimize the incidence of maternal complications. Although several studies demonstrated an association between clinical factors, maternal characteristics, and unsuccessful vaginal delivery after cesarean section, there is actually no evidence that such factors can be useful to predict outcomes in women attempting to deliver vaginally after a previous cesarean surgery.
References
- . Mode of delivery after one cesarean section. Int J Gynaecol Obstet. 2004;87:9–13
- . Risk factors at caesarean section and failure of subsequent trial of labour. Eur J Obstet Gynecol Reprod Biol. 2002;100:163–166
- . Vaginal birth after cesarean: A meta-analysis of morbidity and mortality. Obstet Gynecol. 1991;77:465–470
- . Delivery after previous cesarean: A risk evaluation (Swiss Working Group of Obstetric and Gynecologic Institutions). Obstet Gynecol. 1999;93:332–337
- . Elective repeat cesarean delivery versus trial of labor: A meta-analysis of the literature from 1989 to 1999. Am J Obstet Gynecol. 2000;183:1187–1197
- Meta-analysis of observational studies in epidemiology: A proposal for reporting (Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group). JAMA. 2000;283:2008–2012
- . Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
- . Is vaginal birth after cesarean safe? (Experience at a community hospital). Am J Obstet Gynecol. 2001;184:1478–1484discussion 1484-7
- . Failed vaginal birth after a cesarean section: How risky is it? I (Maternal morbidity). Am J Obstet Gynecol. 2001;184:1365–1371discussion 1371-3
- . Obstetric management and outcome of pregnancy in women with a history of caesarean section in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2007;132:171–176
- Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med. 2004;351:2581–2589
- . Labour and perinatal outcome in women at term with one previous lower-segment Caesarean: A review of 1000 consecutive cases. Aust N Z J Obstet Gynaecol. 2007;47:31–36
- Vaginal birth after caesarean section in a population with a low overall caesarean section rate. Eur J Obstet Gynecol Reprod Biol. 2001;96:158–162
- Short interpregnancy interval: risk of uterine rupture and complications of vaginal birth after cesarean delivery. Obstet Gynecol. 2007;110:1075–1082
- . The effect of birth weight on vaginal birth after cesarean delivery success rates. Am J Obstet Gynecol. 2003;188:824–830
- . Increased success of trial of labor after previous vaginal birth after cesarean. Obstet Gynecol. 2004;104:715–719
- Maternal complications with vaginal birth after cesarean delivery: a multicenter study. Am J Obstet Gynecol. 2005;193:1656–1662
- . Effect of previous vaginal delivery on the risk of uterine rupture during a subsequent trial of labor. Am J Obstet Gynecol. 2000;183:1184–1186
- Is vaginal birth after cesarean (VBAC) or elective repeat cesarean safer in women with a prior vaginal delivery?. Am J Obstet Gynecol. 2006;195:1143–1147
- . Predicting outcomes of trials of labor in women attempting vaginal birth after cesarean delivery: A comparison of multivariate methods with neural networks. Am J Obstet Gynecol. 2001;184:409–413
- . Predicting failure of a vaginal birth attempt after cesarean delivery. Obstet Gynecol. 2007;109:800–805
- . The impact of maternal obesity and weight gain on vaginal birth after cesarean section success. Am J Obstet Gynecol. 2004;191:954–957
- . Effect of body mass index and excessive weight gain on success of vaginal birth after cesarean delivery. Obstet Gynecol. 2005;106:741–746
- Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol. 2006;108:12–20
- The MFMU Cesarean Registry: Factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol. 2005;193:1016–1023
- . Risk of uterine rupture in labor induction of patients with prior cesarean section: an inner city hospital experience. Am J Obstet Gynecol. 2004;190:1476–1478
- . Uterine rupture after induction of labour in women with previous caesarean section. BJOG. 2005;112:451–455
- . Spontaneous versus induced labor after a previous cesarean delivery. Obstet Gynecol. 2003;102:39–44
- . Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med. 2001;345:3–8
- . Uterine rupture with the use of PGE2 vaginal inserts for labor induction in women with previous cesarean sections. J Reprod Med. 2002;47:549–554
- . Vaginal birth after cesarean section versus elective repeat cesarean delivery: Weight-based outcomes. Am J Obstet Gynecol. 2003;188:1516–1520discussion 1520-2
- . Risk of uterine rupture following induction of labour in women with a previous caesarean section in a large UK teaching hospital. J Obstet Gynaecol. 2004;24:264–265
PII: S0002-9378(08)00421-3
doi:10.1016/j.ajog.2008.04.025
© 2008 Mosby, Inc. All rights reserved.
Volume 199, Issue 3 , Pages 224-231, September 2008

